| [1] |
Loibl S, Schmidt A, Gentilini O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients[J]. JAMA Oncol，2015，1(8): 1145-1153.
|
| [2] |
王富文，傅少梅，金玉春，等. 妊娠期乳腺癌临床诊治回顾性分析[J]. 中华外科杂志，2018，56(2): 114-118.
|
| [3] |
Clarke M, Collins R, Draby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials [J]. Lancet，2005, 366(9503): 2087.
|
| [4] |
Mattsson S, Leide-Svegborn S, Andersson M. X-Ray and molecular imaging during pregnancy and breastfeeding - when should we be worried？[J]. Radiat Prot Dosimetry，2021, 195(3/4): 339-348.
|
| [5] |
吴克谨. 从多学科协作入手加强妊娠期乳腺癌个案管理[J]. 中华外科杂志，2020，58(2)：95-98.
|
| [6] |
Peccatori FA, Codacci-Pisanelli G, Del Grande M, et al. Whole body MRI for systemic staging of breast cancer in pregnant women[J], Breast, 2017，35：177-181.
|
| [7] |
Shachar SS, Gallagher K, McGuire K, et al. Multidisciplinary management of breast cancer during pregnancy[J]. Oncologist, 2017, 22(3): 324-334.
|
| [8] |
Woussen S, Lopez-Rendon X, Vanbeckevoort D, et al. Clinical indications and radiation does to the conceptus associated with CT imaging in pregnancy: a retrospective study[J]. Eur Radiol, 2016, 26(4): 979-985.
|
| [9] |
Baker J, Ali A, Groch MW, et al. Bone scanning in pregnant patients with breast carcinoma[J]. Clin Nucl Med，1987，12(7): 519-524.
|
| [10] |
Rodriguez AO, Chew H, Cress R, et al. Evidence of poorer survival in pregnancy-associated breast cancer[J]. Obstet Gynecol, 2008，112(1)：71-78.
|
| [11] |
Dominici LS, Kuerer HM, Babiera G, et al. Wound complications from surgery in pregnancy-associated breast cancer (PABC)[J]. Breast Dis，2010，31(1)：1-5.
|
| [12] |
No authors listed. Committee opinion No. 696: nonobstetric surgery during pregnancy[J]. Obstet Gynecol, 2017，129(4)：777-778.
|
| [13] |
Lee GE, Rosenberg SM, Mayer EL, et al. Contemporary management of breast cancer during preganancy and subsequent lactation in a multicenter cohort of young women with breast cancer[J]. Breast J, 2019, 25(6): 1104-1110.
|
| [14] |
Omranipour R. Surgery for pregnancy-associated breast cancer[J]. Adv Exp Med Biol，2020，1252：95-99.
|
| [15] |
Loibl S, Han SN, von Minckwitz G, et al. Treatment of breast cancer during pregnancy: an observational study[J]. Lancet Oncol, 2012，13(9)：887-896.
|
| [16] |
James AH, Jamison MG, Brancazio LR, et al. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality[J]. Am J Obstet Gynecol, 2006，194(5)：1311-1315.
|
| [17] |
Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy[J]. Blood, 2005，106(2)：401-407.
|
| [18] |
Amant F, Deckers S, Van Calsteren K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting[J]. Eur J Cancer, 2010, 46(18): 3158-3168.
|
| [19] |
Gentilini O, Cremones M, Trifiro G, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer [J]. Ann Oncol, 2004，15(9)：1348-1351.
|
| [20] |
Pandit-Taskar N, Dauer LT, Montgomery L, et al. Organ and fetal absorbed dose estimates from 99mTcsulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients[J]. J Nucl Med, 2006，47(7)：1202-1208.
|
| [21] |
Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction[J]. Lancet Oncol, 2005, 6(5)：328.
|
| [22] |
Greskovich JF Jr, Macklis RM. Radiation therapy in pregnancy: risk calculation and risk minimization[J]. Semin Oncol，2000, 27(6): 633-645.
|
| [23] |
Mazzola R, Corradini S, Eidemüeller M, et al. Modern radiotherapy in cancer treatment during pregnancy[J]. Crit Rev Oncol Hematol，2019，136：13-19.
|
| [24] |
Antypas C, Sandilos P, Kouvaris J, et al. Fetal dose evaluation during breast cancer radiotherapy[J]. Int J Radiat Oncol Biol Phys, 1998, 40(4): 995-999.
|
| [25] |
Viswanathan S, Ramaswamy B. Pregnancy-associated breast cancer[J]. Clin obstet gynecol, 2011, 54(4): 546-555.
|
| [26] |
Germann N, Goffinet F, Goldwasser F. et al. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients[J]. Ann Oncol, 2004, 15(1): 146-150.
|
| [27] |
Cardonick E, Gilmandyar D, Somer RA. Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy[J]. Obstet Gynecol, 2012, 120(6): 1267-1272.
|
| [28] |
Amant F, Deckers S, Van Calsteren K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting[J]. Eur J Cancer, 2010, 46(18): 3158-3168.
|
| [29] |
Chavez-MacGregor M, Clarke CA, Lichtensztajn DY, et al. Delayed initiation of adjuvant chemotherapy among patients with breast cancer[J]. JAMA Oncology, 2016，2(3)：322-329.
|
| [30] |
No authors listed. HERCEPTIN® (trastuzumab) Intravenous Infusion Initial U．S.Approval: 1998.[2020-08-13]．
URL
|
| [31] |
Isaacs RJ, Hunter W, Clark K, et al. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy--case report and literature review[J]. Gynecol Oncol, 2001, 80(3): 405-408.
|